{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T22:33:23Z","timestamp":1777502003198,"version":"3.51.4"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T00:00:00Z","timestamp":1754524800000},"content-version":"vor","delay-in-days":218,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006662","name":"Ardabil University of Medical Sciences","doi-asserted-by":"publisher","award":["9605"],"award-info":[{"award-number":["9605"]}],"id":[{"id":"10.13039\/501100006662","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research Reports"],"published-print":{"date-parts":[[2025]]},"DOI":"10.1016\/j.lrr.2025.100537","type":"journal-article","created":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T15:22:45Z","timestamp":1754925765000},"page":"100537","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["The synergistic effect of 2-deoxy-D-glucose and cytarabine on mitochondria of stem-like cells derived from KG1-a"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4435-0742","authenticated-orcid":false,"given":"Sona","family":"Rezaei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3570-6834","authenticated-orcid":false,"given":"Mohammad","family":"Mohammadzadeh-Vardin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6761-1736","authenticated-orcid":false,"given":"Keyvan","family":"Amirshahrokhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2666-7519","authenticated-orcid":false,"given":"Mojtaba","family":"Amani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.lrr.2025.100537_bib0001","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1182\/asheducation-2016.1.348","article-title":"| Informed decisions in acute myeloid leukemia: beyond morphology and cytogenetics | mutations in AML: prognostic and therapeutic implications","volume":"30","author":"Dinardo","year":"2016","journal-title":"Am. Soc. Hematol."},{"key":"10.1016\/j.lrr.2025.100537_bib0002","doi-asserted-by":"crossref","unstructured":"C. Saygin, D. Matei, R. Majeti, O. Reizes, and J.D. Lathia, \u201cCell stem cell perspective targeting cancer stemness in the clinic: from hype to hope,\u201d 2019. doi: 10.1016\/j.stem.2018.11.017.","DOI":"10.1016\/j.stem.2018.11.017"},{"issue":"June","key":"10.1016\/j.lrr.2025.100537_bib0003","article-title":"Leukemia Research reports durable remission of acute myeloid leukemia in an elderly patient following a limited course of azacitidine and venetoclax","volume":"18","author":"Ehsan","year":"2022","journal-title":"Leuk. Res. Rep."},{"issue":"S1","key":"10.1016\/j.lrr.2025.100537_bib0004","doi-asserted-by":"crossref","first-page":"14","DOI":"10.5045\/br.2020.S003","article-title":"New agents in acute myeloid leukemia (AML)","volume":"55","author":"Park","year":"2020","journal-title":"Blood Res."},{"issue":"6","key":"10.1016\/j.lrr.2025.100537_bib0005","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.stem.2012.05.007","article-title":"Cancer stem cells: current status and evolving complexities","volume":"10","author":"Visvader","year":"2012","journal-title":"Cell Stem Cell"},{"issue":"1","key":"10.1016\/j.lrr.2025.100537_bib0007","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12943-016-0572-9","article-title":"The evolving concept of liver cancer stem cells","volume":"16","author":"Nio","year":"2017","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.lrr.2025.100537_bib0009","series-title":"Metformin as an Enhancer for the Treatment of Chemoresistant","author":"Acute","year":"2024"},{"key":"10.1016\/j.lrr.2025.100537_bib0010","series-title":"PTEN \/AKT Signaling Mediates Chemoresistance in Refractory Acute Myeloid Leukemia Through Enhanced Glycolysis","first-page":"2149","author":"Ryu","year":"2019"},{"key":"10.1016\/j.lrr.2025.100537_bib0011","series-title":"Mitochondria : A Galaxy in the Hematopoietic and Leukemic Stem Cell Universe","author":"Panuzzo","year":"2020"},{"issue":"8053","key":"10.1016\/j.lrr.2025.100537_bib0012","doi-asserted-by":"crossref","first-page":"E5","DOI":"10.1038\/s41586-025-08764-y","article-title":"Publisher correction: immune evasion through mitochondrial transfer in the tumour microenvironment","volume":"639","author":"Ikeda","year":"2025","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.lrr.2025.100537_bib0013","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41419-022-05023-0","article-title":"Stabilization of SAMHD1 by NONO is crucial for Ara-C resistance in AML","volume":"13","author":"Zhang","year":"2022","journal-title":"Cell Death. Dis."},{"key":"10.1016\/j.lrr.2025.100537_bib0016","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1532857","article-title":"Mitochondrial abnormalities as a target of intervention in acute myeloid leukemia","volume":"14","author":"Tjahjono","year":"2025","journal-title":"Front. Oncol."},{"issue":"2","key":"10.1016\/j.lrr.2025.100537_bib0017","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1177\/1078155219848800","article-title":"Cytarabine ears \u2013 a side effect of cytarabine therapy","volume":"26","author":"Doval","year":"2020","journal-title":"J. Oncol. Pharmacy Pract."},{"issue":"1","key":"10.1016\/j.lrr.2025.100537_bib0015","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/bjc.1991.234","article-title":"1-\u03b2-d-Ar abinofuranosylcytosine (Ara-C) enhances mitochondrial activities in human leukaemic cells","volume":"64","author":"Muus","year":"1991","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.lrr.2025.100537_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114213","article-title":"Cellular toxicity of the metabolic inhibitor 2-deoxyglucose and associated resistance mechanisms","volume":"182","author":"Laussel","year":"2020","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.lrr.2025.100537_bib0019","doi-asserted-by":"crossref","first-page":"234","DOI":"10.3390\/ijms21010234","article-title":"2-Deoxy-d-glucose and its analogs: from diagnostic to therapeutic agents","volume":"21","author":"Pajak","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.lrr.2025.100537_bib0020","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/sj.bjc.6600547","article-title":"Evaluation of 2-deoxy-d-glucose as a chemotherapeutic agent: mechanism of cell death","volume":"87","author":"Aft","year":"2002","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.lrr.2025.100537_bib0021","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-01402-7","article-title":"The effect of 2-deoxy-d-glucose on glycolytic metabolism in acute myeloblastic leukemic ML-1 cells","volume":"15","author":"Christensen","year":"2025","journal-title":"Sci. Rep."},{"issue":"10","key":"10.1016\/j.lrr.2025.100537_bib0022","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1158\/1535-7163.MCT-15-0163","article-title":"Antileukemic activity of 2-deoxy- <scp>d<\/scp>-glucose through inhibition of N-linked glycosylation in acute myeloid leukemia with FLT3-ITD or c-KIT mutations","volume":"14","author":"Larrue","year":"2015","journal-title":"Mol. Cancer Ther."},{"issue":"2","key":"10.1016\/j.lrr.2025.100537_bib0023","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.canlet.2011.12.017","article-title":"Resistance of leukemic stem-like cells in AML cell line KG1a to natural killer cell-mediated cytotoxicity","volume":"318","author":"She","year":"2012","journal-title":"Cancer Lett."},{"issue":"3","key":"10.1016\/j.lrr.2025.100537_bib0025","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1124\/pr.58.3.10","article-title":"Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies","volume":"58","author":"Chou","year":"2006","journal-title":"Pharmacol. Rev."},{"issue":"34","key":"10.1016\/j.lrr.2025.100537_bib0057","doi-asserted-by":"crossref","first-page":"4633","DOI":"10.1038\/sj.onc.1209597","article-title":"Glycolysis inhibition for anticancer treatment","volume":"25","author":"Pelicano","year":"2006","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.lrr.2025.100537_bib0058","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1182\/blood-2005-08-3351","article-title":"Pharmacodynamics of cytarabine alone and in combination with 7-hydroxystaurosporine (UCN-01) in AML blasts in vitro and during a clinical trial","volume":"107","author":"Sampath","year":"2006","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.lrr.2025.100537_bib0059","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","article-title":"Drug combination studies and their synergy quantification using the Chou-Talalay method","volume":"70","author":"Chou","year":"2010","journal-title":"Cancer Res."},{"issue":"7","key":"10.1016\/j.lrr.2025.100537_bib0060","first-page":"226","article-title":"Impact of clinical officer anaesthetist training programme AT the Kenya medical Training College, Nakuru, on trainee satisfaction, quality of practice, and cadre shortfall alleviation","volume":"90","author":"Nyamai","year":"2013","journal-title":"East Afr. Med. J."},{"key":"10.1016\/j.lrr.2025.100537_bib0026","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.659253","article-title":"Escape from treatment; the different faces of leukemic stem cells and therapy resistance in acute myeloid leukemia","volume":"11","author":"van Gils","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.lrr.2025.100537_bib0027","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.semcancer.2017.06.012","article-title":"Mitochondrial biology in cancer stem cells","volume":"47","author":"Loureiro","year":"2017","journal-title":"Semin. Cancer Biol."},{"issue":"8","key":"10.1016\/j.lrr.2025.100537_bib0029","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0006-2952(01)00548-2","article-title":"Involvement of oxygen radicals in cytarabine-induced apoptosis in human polymorphonuclear cells11Abbreviations: ROS, reactive oxygen species; PMNs, polymorphonuclear neutrophils; SOD, superoxide dismutase; Ara-C, cytarabine; ara-CTP, cytarabine 5\u2032-triphos","volume":"61","author":"Iacobini","year":"2001","journal-title":"Biochem. Pharmacol."},{"issue":"January","key":"10.1016\/j.lrr.2025.100537_bib0030","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.freeradbiomed.2018.04.570","article-title":"Neurotoxicity of cytarabine (Ara-C) in dorsal root ganglion neurons originates from impediment of mtDNA synthesis and compromise of mitochondrial function","volume":"121","author":"Zhuo","year":"2018","journal-title":"Free Radic. Biol. Med."},{"issue":"5","key":"10.1016\/j.lrr.2025.100537_bib0031","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms22052470","article-title":"Oxidative stress and ros-mediated signaling in leukemia: novel promising perspectives to eradicate chemoresistant cells in myeloid leukemia","volume":"22","author":"Trombetti","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lrr.2025.100537_bib0032","doi-asserted-by":"crossref","unstructured":"J.S. Khorashad, S. Rizzo, and A. Tonks, \u201cReactive oxygen species and its role in pathogenesis and resistance to therapy in acute myeloid leukemia,\u201d 2024, doi: 10.20517\/cdr.2023.125.","DOI":"10.20517\/cdr.2023.125"},{"issue":"20","key":"10.1016\/j.lrr.2025.100537_bib0033","doi-asserted-by":"crossref","first-page":"5191","DOI":"10.1158\/0008-5472.CAN-19-0515","article-title":"Targeting myeloperoxidase disrupts mitochondrial redox balance and overcomes cytarabine resistance in Human acute myeloid leukemia","volume":"79","author":"Hosseini","year":"2019","journal-title":"Cancer Res."},{"issue":"10","key":"10.1016\/j.lrr.2025.100537_bib0034","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1158\/2159-8290.CD-19-1008","article-title":"Extracellular ATP and CD39 activate cAMP-mediated mitochondrial stress response to promote cytarabine resistance in acute myeloid leukemia","volume":"10","author":"Aroua","year":"2020","journal-title":"Cancer Discov."},{"key":"10.1016\/j.lrr.2025.100537_bib0035","unstructured":"I. Fokt, M. Ziemniak, and A. Ja, \u201c2-Deoxy- d -glucose and its analogs : from diagnostic to therapeutic agents,\u201d 2020."},{"key":"10.1016\/j.lrr.2025.100537_bib0036","doi-asserted-by":"crossref","unstructured":"R. Singh, V. Gupta, A. Kumar, and K. Singh, \u201c2-Deoxy-d-glucose : a novel pharmacological agent for killing hypoxic tumor cells, oxygen dependence-lowering in Covid-19, and other pharmacological activities,\u201d vol. 2023, 2023.","DOI":"10.1155\/2023\/9993386"},{"issue":"6","key":"10.1016\/j.lrr.2025.100537_bib0037","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1038\/s41556-022-00925-9","article-title":"The metabolic enzyme hexokinase 2 localizes to the nucleus in AML and normal haematopoietic stem and progenitor cells to maintain stemness","volume":"24","author":"Thomas","year":"2022","journal-title":"Nat. Cell Biol."},{"issue":"15","key":"10.1016\/j.lrr.2025.100537_bib0038","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms21155276","article-title":"Increased oxidative phosphorylation is required for stemness maintenance in liver cancer stem cells from hepatocellular carcinoma cell line HCCLM3 cells","volume":"21","author":"Liu","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.lrr.2025.100537_bib0039","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0115250","article-title":"Apoptotic efficacy of etomoxir in human acute myeloid leukemia cells. Cooperation with arsenic trioxide and glycolytic inhibitors, and regulation by oxidative stress and protein kinase activities","volume":"9","author":"Esta\u00f1","year":"2014","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.lrr.2025.100537_bib0040","first-page":"1","article-title":"Selected polyphenols potentiate the apoptotic efficacy of glycolytic inhibitors in human acute myeloid leukemia cell lines. Regulation by protein kinase activities","volume":"16","author":"Blas","year":"2016","journal-title":"Cancer Cell Int."},{"issue":"3","key":"10.1016\/j.lrr.2025.100537_bib0041","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.3892\/mmr.2014.2945","article-title":"Glycolysis inhibitor 2-deoxy-d-glucose suppresses carcinogen-induced rat hepatocarcinogenesis by restricting cancer cell metabolism","volume":"11","author":"WANG","year":"2015","journal-title":"Mol. Med. Rep."},{"issue":"1","key":"10.1016\/j.lrr.2025.100537_bib0042","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-29039-4","article-title":"Phase II trial of cytarabine and mitoxantrone with devimistat in acute myeloid leukemia","volume":"13","author":"Anderson","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.lrr.2025.100537_bib0043","doi-asserted-by":"crossref","unstructured":"C.M. Gorospe, G. Carvalho, A.H. Curbelo, L. Marchhart, I.C. Mendes, and P.H. Wanrooij, \u201cMitochondrial membrane potential acts as a retrograde signal to regulate cell cycle progression,\u201d vol. 6, no. 12, pp. 1\u201314, 2023, doi: 10.26508\/lsa.202302091.","DOI":"10.26508\/lsa.202302091"},{"issue":"7","key":"10.1016\/j.lrr.2025.100537_bib0044","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1158\/2159-8290.CD-16-0441","article-title":"Chemotherapy-resistant Human acute myeloid leukemia cells are not enriched for leukemic stem cells but require oxidative metabolism","volume":"7","author":"Farge","year":"2017","journal-title":"Cancer Discov."},{"key":"10.1016\/j.lrr.2025.100537_bib0045","doi-asserted-by":"crossref","DOI":"10.1158\/0008-5472.CAN-19-0515","article-title":"Targeting myeloperoxidase disrupts mitochondrial redox balance and overcomes cytarabine resistance in Human acute myeloid leukemia","author":"Hosseini","year":"2019","journal-title":"Cancer Res."},{"issue":"7","key":"10.1016\/j.lrr.2025.100537_bib0046","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1158\/2159-8290.CD-16-0441","article-title":"Chemotherapy-resistant Human acute myeloid leukemia cells are not enriched for leukemic stem cells but require oxidative metabolism","volume":"7","author":"Farge","year":"2017","journal-title":"Cancer Discov."},{"issue":"1","key":"10.1016\/j.lrr.2025.100537_bib0047","first-page":"1","article-title":"EIF4A inhibition targets bioenergetic homeostasis in AML MOLM-14 cells in vitro and in vivo and synergizes with cytarabine and venetoclax","volume":"41","author":"Fooks","year":"2022","journal-title":"J. Exp. Clinic. Cancer Res."},{"issue":"1","key":"10.1016\/j.lrr.2025.100537_bib0048","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-26829-0","article-title":"2-Deoxy-d-glucose couples mitochondrial DNA replication with mitochondrial fitness and promotes the selection of wild-type over mutant mitochondrial DNA","volume":"12","author":"Pantic","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.lrr.2025.100537_bib0049","doi-asserted-by":"crossref","unstructured":"S. Pandey et al., \u201cDietary administration of the glycolytic inhibitor 2-deoxy-d-glucose reduces in fl ammation and oxidative stress : implications in PAMP-associated acute and chronic pathology,\u201d no. May, pp. 1\u201313, 2023, doi: 10.3389\/fphar.2023.940129.","DOI":"10.3389\/fphar.2023.940129"},{"issue":"2","key":"10.1016\/j.lrr.2025.100537_bib0050","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/JLB.6A0821-409RR","article-title":"Bone marrow microenvironment drives AML cell OXPHOS addiction and AMPK inhibition to resist chemotherapy","volume":"112","author":"You","year":"2022","journal-title":"J. Leukoc. Biol."},{"issue":"11","key":"10.1016\/j.lrr.2025.100537_bib0051","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2017.482","article-title":"Metformin ameliorates arsenic trioxide hepatotoxicity via inhibiting mitochondrial complex i","volume":"8","author":"Ling","year":"2017","journal-title":"Cell Death. Dis."},{"key":"10.1016\/j.lrr.2025.100537_bib0052","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.115029","article-title":"2-Deoxy-d-glucose increases the sensitivity of glioblastoma cells to BCNU through the regulation of glycolysis, ROS and ERS pathways: in vitro and in vivo validation","volume":"199","author":"Sun","year":"2022","journal-title":"Biochem. Pharmacol."},{"issue":"12","key":"10.1016\/j.lrr.2025.100537_bib0053","article-title":"Metabolic rewiring in drug resistant cells exhibit higher OXPHOS and fatty acids as preferred major source to cellular energetics","volume":"1861","author":"Salunkhe","year":"2020","journal-title":"Biochim. Biophys. Acta"},{"issue":"10","key":"10.1016\/j.lrr.2025.100537_bib0014","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1158\/2159-8290.CD-19-1008","article-title":"Extracellular atp and cd39 activate camp-mediated mitochondrial stress response to promote cytarabine resistance in acute myeloid leukemia","volume":"10","author":"Aroua","year":"2020","journal-title":"Cancer Discov."},{"issue":"4","key":"10.1016\/j.lrr.2025.100537_bib0054","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.3892\/or.2017.5491","article-title":"Co-treatment of breast cancer cells with pharmacologic doses of 2-deoxy-d-glucose and metformin: starving tumors","volume":"37","author":"Wokoun","year":"2017","journal-title":"Oncol. Rep."},{"issue":"8","key":"10.1016\/j.lrr.2025.100537_bib0028","doi-asserted-by":"crossref","DOI":"10.1007\/s12032-020-01394-6","article-title":"Acute myeloid leukemia sensitivity to metabolic inhibitors: glycolysis showed to be a better therapeutic target","volume":"37","author":"Lapa","year":"2020","journal-title":"Med. Oncol."},{"key":"10.1016\/j.lrr.2025.100537_bib0056","series-title":"Insights into Metabolic Reprogramming in Tumor Evolution and Therapy","first-page":"1","author":"Chiu","year":"2024"},{"issue":"10","key":"10.1016\/j.lrr.2025.100537_fur1","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.3390\/cancers14102485","article-title":"Diphenyleneiodonium triggers cell death of acute myeloid leukemia cells by blocking the mitochondrial Respiratory chain, and synergizes with cytarabine, Cancers","volume":"14","author":"Dakik","year":"2022","journal-title":"(Basel)"}],"container-title":["Leukemia Research Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213048925000391?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213048925000391?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T12:48:14Z","timestamp":1764852494000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213048925000391"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":57,"alternative-id":["S2213048925000391"],"URL":"https:\/\/doi.org\/10.1016\/j.lrr.2025.100537","relation":{},"ISSN":["2213-0489"],"issn-type":[{"value":"2213-0489","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The synergistic effect of 2-deoxy-D-glucose and cytarabine on mitochondria of stem-like cells derived from KG1-a","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lrr.2025.100537","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100537"}}